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Background: Cardiovascular disease (CVD) is a significant cause of morbidity and mor-
tality	globally.	Obesity	is	an	important	CVD	risk	factor	and	is	increasing	in	prevalence.
Methods: In	this	study,	3829	men	and	5720	women	(35-65	years)	were	enrolled	as	
part	 of	 the	MASHAD	 cohort	 study.	 Four	 categories	 were	 identified	 according	 to	
body	mass	 index	 and	waist	 circumference	 that	 was	 defined	 by	 the	World	 Health	
Organization.	Logistic	regression	analysis	was	used	to	determine	the	adjusted	odds	
ratio	(OR)	for	the	occurrence	of	CVD,	and	Cox	regression	model	was	used	to	evaluate	
the association of obesity with CVD incidence.
Results: We	found	that	the	higher	risk	groups	defined	by	categories	of	adiposity	were	
significantly	related	to	a	higher	prevalence	of	a	high	serum	total	cholesterol	(TC),	and	
triglycerides	 (TG),	and	 lower	high-density	 lipoprotein	cholesterol	 (HDL),	and	higher	
fasting	blood	glucose	(FBG)	in	both	genders	and	a	higher	low-density	lipoprotein	cho-
lesterol	 (LDL)	 in	women	 (P	 <	 .001).	Additionally,	 a	 high	 percentage	of	 participants	
with	dyslipidemia,	high	LDL,	high	TC,	and	low	HDL	and	a	high	percentage	of	partici-
pants	with	metabolic	syndrome,	diabetes,	hypertension,	and	a	high	serum	TG	were	





cardiovascular events in women compared with men.






has the highest prevalence of childhood obesity among countries 
presented	in	the	report	of	the	World	Health	Organization	(WHO).	
Over	 one	 billion	 adults	 worldwide	 are	 suffering	 from	 excess	
weight.	 Obesity	 is	 a	 multifactorial	 disorder,	 and	 environmental	
causes	 such	 as	 lifestyle,	 unhealthy	diets,	 and	physical	 inactivity,	
as	well	 as	 genetic	 causes,	 are	 risk	 factors	 for	excess	weight	 and	
obesity	which	 is	 associated	with	 several	 non-communicable	 dis-
eases	 including	 diabetes,	 arthritis,	 hypertension,	 hyperlipidemia,	
and cardiovascular diseases (CVD).1-7 CVD is a primary chronic 
non-communicable	 disease	 that	 can	 be	 the	 cause	 of	 disability,	













It	 has	 been	 shown	 that	 there	 are	 gender-dependent	 car-
diometabolic	differences,	while	the	role	of	gender	in	the	severity	
of obesity is not apparent.13	Therefore,	we	conducted	this	study	
to investigate the predictive values of anthropometric indices for 
CVD	risk	factors	in	Iranian	men	and	women	with	different	degrees	
of obesity.
2  | MATERIAL S AND METHODS
2.1 | Study population
The population in this study comprised 3829 men with aged 
49.12 ± 8.37 years and 5720 women with an mean age of 
46.99	±	8.02	years	 that	were	enrolled	 from	the	Mashhad	stroke	
and	 heart	 atherosclerotic	 disorder	 (MASHAD)	 cohort	 study.	
MASHAD	 study	 aimed	 to	 identify	 the	 risk	 and	 incidence	of	 car-
diovascular events as described elsewhere.14 Those participants 








In	 the	MASHAD	 study,	 biochemical	 parameters	 (including	 fasting	
blood	 glucose	 [FBG]	 and	 lipid	 profiles),	 demographic	 data	 (includ-
ing	educational	 level,	gender,	and	age)	and	medical	history	as	well	
as	 lifestyle	 information	 (including	 smoking	 habit),	 anthropometric	
data	 (including	waist	 circumference	 [WC],	body	mass	 index	 [BMI],	
weight,	and	height)	and	physical	activity	 (by	Self-declaration	form)	
were gathered by a nurse interview.15 The methods of biochemical 
measurements using an automated analyzer and blood pressure as-
sessments using a standard mercury sphygmomanometer are de-
scribed elsewhere.16 Participants with dyslipidemia were defined by 
lipid	profiles,	as	described	previously.17
We	 used	 the	 BMI	 categories	 as	 defined	 by	 the	World	 Health	
Organization	 (WHO)	 recommendations	 for	 obesity	 Table	 1.	 Also,	
the	 following	 four	 categories	 were	 used:	 underweight,	 normal,	
Funding information
This study was supported by grant from 
Research	Council	of	the	Mashhad	University	
of	Medical	Sciences.
K E Y W O R D S
cardiovascular	risk	factors,	obesity
BMI classification BMI (kg/m2) Waist circumference  
  Men	<	102	cm
Women < 88 cm
Men	>	102	cm
Women	>	88	cm
Underweight <18.5 No	increased	risk No	increased	risk
Normal 18.5-24.9 No	increased	risk No	increased	risk







Extreme	obesity ≥40 Very	high	risk Very	high	risk
Note: Obesity	categories	as	defined	by	World	Health	Organization	recommendations.
Abbreviations:	BMI,	body	mass	index.
TA B L E  1   Categories of obesity based 
on	combined	BMI	and	WC,	in	accordance	
with	the	NIH	Practical	guide	to	obesity18
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overweight,	obesity,	 and	extreme	obesity	 for	 the	current	analysis.	
According	 to	 the	WHO	 recommendations	 for	 obesity,	 BMI	 more	
than	 25	 kg/m2	 was	 defined	 as	 overweight,	 and	 BMI	 higher	 than	











The	 participants	 with	 CVD	 were	 approved	 at	 follow-up	 to	 assess	
medical	history	and	physical	test	by	an	expert	Cardiologist.	These	data	
were	collected	during	three	follow-up	periods;	a	total	of	768	subjects	
claimed	 to	 have	 a	 CVD	 event.	 Further	 assessments	 of	 participants	
were	performed,	including	a	history	of	myocardial	infarction	or	angina	




















determined	 the	 normality	 of	 data	 using	 the	 Kolmogorov-Smirnov	
test.	Based	on	data	distribution	pattern,	Student's	t	test,	analysis	of	
variance	(ANOVA),	Mann-Whitney	U,	and	Kruskal-Wallis	tests	were	















Tables 2 and 3 show a significant incremental rise in level of 
serum	 lipid	profiles	 (TC,	TG,	LDL,	and	HDL),	FBG,	anthropometric	
factors	(BMI,	WC,	HC,	WHR,	WHtR,	and	MAC)	and	SBP,	DBP	with	
an increasing degree of obesity in men and women participants 
(P	<	 .001).	We	observed	that	very	high-risk	men	and	women	were	

















3.2 | Association of CVD risk factors with 
obesity categories
Participants	 at	 raised	CVD	 risk	were	 examined	 using	 the	multiple	















in	women	group,	 respectively),	 and	MetS	 (OR:	8.98,	21	and	33.51	
in	men	group	and	OR:	1.19,	3.20	and	5.04	in	women	group,	respec-
tively),	while	 high-risk	women	had	 significantly	 higher	 risk	of	 high	





factors	 of	 diabetes,	 hypertension,	 high	 TG,	 high	 TC,	 dyslipidemia,	
and	MetS.	The	 results	demonstrated	 that	CVD	risk	 factors	have	a	
graded	linear	relationship	with	risk	categories,	before	and	after	ad-
justing for confounding factors.
In	 this	 regard,	 very	 high-risk	 participants	 had	 a	 significantly	
higher	 risk	 of	MetS	 in	 comparison	with	 reference	 group	 (No	 risk)	






2.28-3.71;	P:	 <.00	1	 and	OR:	2.92;	95%	CI:	2.36-3.61;	P: <.001 in 
men	 and	women,	 respectively),	 high	 TG	 (OR:	 3.83;	 95%	CI:	 3.04-
4.83; P:	<.00	1	and	OR:	2.60;	95%	CI:	2.15-3.15;	P: <.001 in men and 
women,	respectively),	and	high	TC	(OR:	1.53;	95%	CI:	1.22-1.91;	P: 
TA B L E  2  Characteristics	of	participants	based	on	the	NIH	Practical	guide	to	obesity	categories	in	men
 
Obesity categories
PNo risk Increased risk High risk Very high risk
Number,	n 1427 1405 506 491  
Age,	y 48.26 ± 8.61 48.61 ± 8.30 50.48 ± 8.34 49.16 ± 8.24 <.001
BMI,	kg/m2 22.21 ± 2.09 27.15 ± 1.33 29.19 ± 1.96 33.03 ± 2.51 <.001
WC,	cm 84.76 ± 8.12 93.82 ± 5.69 102.30 ± 6.64 109.95 ± 6.33 <.001
HC,	cm 95.17 ± 5.68 101.42 ± 5.24 105.50 ± 5.27 112.46 ± 6.15 <.001
WHR 0.89 ± 0.07 0.93 ± 0.06 0.97 ± 0.06 0.98 ± 0.05 <.001
WHtR 0.50 ± 4.75 0.56 ± 3.64 0.61 ± 4.03 0.65 ± 4.31 <.001
MAC,	cm 27.99 ± 3.58 30.69 ± 3.53 31.77 ± 2.42 33.87 ± 3.40 <.001
SBP,	mm	Hg 117.95 ± 16.10 122.54 ± 16.36 127.03 ± 17.10 129.34 ± 18.51 <.001
DBP,	mm	Hg 80 ± 10.25 80.46 ± 10.14 83.15 ± 10.57 84.43 ± 10.56 <.001
TC,	mg/dL 180.36 ± 37.68 190.19 ± 36.21 190.26 ± 40.11 192.10 ± 38.27 <.001
TG,	mg/dL 98	(72,	137) 138.50	(97,	196) 144	(102,	197.25) 153	(114,	214) <.001
LDL-C,	mg/dL 112.42 ± 33.24 114.14 ± 34.15 113.95 ± 37.55 114.32 ± 35.72 .521
HDL-C,	mg/dL 41.60 ± 9.52 38.92 ± 8.91 38.93 ± 8.41 38.54 ± 9.47 <.001
FBG,	mg/dL 86.46 ± 34.21 91.54 ± 34.59 95.59 ± 38.40 96.57 ± 41.54 <.001
CVD	risk	factors
Prevalence,	%
Diabetes 5.20 8.90 10.30 11.40 <.001
Hypertension 16.50 24.60 31.80 38.70 <.001
High TC 28.60 37.10 36.60 39.90 <.001
High TG 19.80 44.70 46.40 53 <.001
High	LDL-C 27.50 30.40 30.60 33.60 .057
Low	HDL-C 46.40 60.80 59.10 60.30 <.001
Dyslipidemia 70.20 85.30 85.40 89.40 <.001
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<.001	and	OR:	1.58;	95%	CI:	1.33-1.86;	P	<	.001	in	men	and	women,	
respectively).
After	 adjusting	 for	 confounding	 factors,	we	did	not	 find	 a	 sig-
nificant	association	between	high	LDL-C	and	degree	of	risk	in	men	




CI:	1.15-1.78;	P:	 .001)	and	women	 (odds	 ratio:	1.36;	95%	CI:	1.11-
1.54; P:	.001),	respectively.
According	 to	 Table	 5	 and	 after	 adjusting	 for	 confounding	 fac-
tors,	we	demonstrated	that	women	with	a	very	high	risk	of	obesity	
in	 comparison	with	 the	 reference	 group	 (no	 risk)	 had	 significantly	
increased	the	risk	of	CVD	(HR:	1.91,95%	CI:	1.06-3.43;	P: .03) while 
these association were not significant among men.
4  | DISCUSSION
In	the	present	study,	after	6	years	of	follow-up,	CVD	was	reported	in	





tion between genetic and environmental factors with cardiometa-
bolic	risk	factors	such	as	obesity	and	metabolic	syndrome.21-24	Sertic	
and colleagues reported an association between anthropometric 
factors	 including	weight,	BMI,	and	waist-hip	ratio	 (WHR)	with	diet	
type.	Additionally,	 these	 results	 showed	 that	 several	 genetic	 vari-
ants	(ESR-1,	LPL,	and	APO	E)	could	be	considered	as	predictive	ge-
netic	risk	factors	for	obesity-related	metabolic	disorders	in	healthy	
TA B L E  3  Characteristics	of	participants	by	NIH	Practical	guide	to	obesity	categories	in	women
 
Obesity categories
P-valueNo risk Increased risk High risk Very high risk
Number,	n 1202 577 1840 2101  
Age,	y 46.76 ± 8.36 45.15 ± 7.87 47.77 ± 7.95 48.29 ± 7.90 <.001
BMI,	kg/m2 22.64 ± 1.92 27.06 ± 1.38 28.01 ± 1.66 33.78 ± 3.29 <.001
WC,	cm 84.72 ± 9.59 81.62 ± 4.49 96.71 ± 7.16 106.12 ± 9.85 <.001
HC,	cm 95.43 ± 6.05 100.07 ± 5.67 104.19 ± 5.20 113.86 ± 8.27 <.001
WHR 0.89 ± 0.08 0.82 ± 0.06 0.93 ± 0.07 0.93 ± 0.07 <.001
WHtR 0.54 ± 6.23 0.53 ± 3.38 0.62 ± 4.69 0.69 ± 6.38 <.001
MAC,	cm 27.37 ± 2.93 28.98 ± 3.49 30.54 ± 2.94 33.28 ± 3.61 <.001
SBP,	mm	Hg 114.79 ± 17.12 115.65 ± 26.34 122.35 ± 19.28 125.75 ± 19.55 <.001
DBP,	mm	Hg 74.57 ± 13.01 75.08 ± 10.32 79.16 ± 12.99 81.15 ± 11.39 <.001
TC,	mg/dL 186.76 ± 39.24 189.11 ± 36.38 196.20 ± 39.15 198.19 ± 39.88 <.001
TG,	mg/dL 92	(68,	132) 106	(74,	145) 118	(86,	168) 132	(97,	182) <.001
LDL-C,	mg/dL 114.90 ± 35.46 113.08 ± 32.95 121.23 ± 35.42 120.19 ± 35.95 <.001
HDL-C,	mg/dL 47.25 ± 10.52 44.99 ± 10.12 44.76 ± 9.82 43.63 ± 9.22 <.001
FBG,	mg/dL 87.68 ± 40.07 87.47 ± 34.57 93.52 ± 40.72 93.75 ± 35.29 <.001
CVD	risk	factors
Prevalence,	%
Diabetes 6.10 5.90 9 9.50 .001
Hypertension 12.90 13.50 24.20 30.30 <.001
High TC 33.80 34.80 44.90 44.60 <.001
High TG 17.70 23.10 32.80 40.30 <.001
High	LDL-C 30.70 28.10 37.90 36.40 <.001
Low	HDL-C 64.90 72.30 73.30 77.30 <.001
Dyslipidemia 81.60 85.60 90.80 92.20 <.001
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TA B L E  4  Odds	ratio	of	CVD	risk	factors	based	on	obesity	categories
 
Men Women
Model 1 Model 2 Model 1 Model 2
Diabetes
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.79	(1.33-2.41) 1.58	(1.16-2.15) 0.97	(0.64-1.47) 0.97	(0.64-1.48)
High	risk 2.10	(1.45-3.04) 1.70	(1.15-2.51) 1.53	(1.15-2.04) 1.44	(1.07-1.93)
Very	high	risk 2.36	(1.64-3.39) 1.90	(1.29-2.77) 1.62	(1.23-2.14) 1.45	(1.07-1.98)
P-value <.001 .001 .001 .018
Hypertension
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.65	(1.37-1.99) 1.56	(1.28-1.89) 1.06	(0.79-1.41) 1.08	(0.80-1.44)
High	risk 2.36	(1.87-2.98) 2.14	(1.68-2.73) 2.16	(1.77-2.63) 2.11	(1.72-2.59)
Very	high	risk 3.19	(2.54-4.02) 2.91	(2.28-3.71) 2.94	(2.42-3.56) 2.92	(2.36-3.61)
P-value <.001 <.001 <.001 <.001
High TC
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.47	(1.26-1.72) 1.40	(1.19-1.65) 1.05	(0.85-1.29) 1.06	(0.86-1.30)
High	risk 1.44	(1.16-1.78) 1.34	(1.07-1.67) 1.60	(1.37-1.86) 1.58	(1.35-1.85)
Very	high	risk 1.66	(1.34-2.05) 1.53	(1.22-1.91) 1.58	(1.36-1.83) 1.58	(1.33-1.86)
P-value <.001 <.001 <.001 <.001
High TG
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 3.27	(2.77-3.87) 2.99	(2.51-3.55) 1.39	(1.09-1.77) 1.34	(1.05-1.71)
High	risk 3.51	(2.83-4.37) 3.03	(2.41-3.80) 2.26	(1.90-2.70) 2.07	(1.73-2.48)
Very	high	risk 4.56	(3.66-5.68) 3.83	(3.04-4.83) 3.13	(2.64-3.72) 2.60	(2.15-3.15)
P-value <.001 <.001 <.001 <.001
High	LDL-C
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.15	(0.98-1.36) 1.10	(0.93-1.30) 0.88	(0.71-1.10) 0.88	(0.71-1.10)
High	risk 1.16	(0.93-1.45) 1.07	(0.85-1.35) 1.38	(1.18-1.61) 1.35	(1.15-1.59)
Very	high	risk 1.34	(1.07-1.66) 1.22	(0.97-1.54) 1.29	(1.11-1.50) 1.27	(1.07-1.50)
P-value .010 .091 .001 .006
Low	HDL-C
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.79	(1.55-2.08) 1.62	(1.38-1.89) 1.41	(1.13-1.75) 1.34	(1.08-1.67)
High	risk 1.67	(1.36-2.05) 1.40	(1.13-1.74) 1.48	(1.27-	1.74) 1.31	(1.11-1.54)
Very	high	risk 1.76	(1.43-2.16) 1.43	(1.15-1.78) 1.84	(1.57-2.15) 1.36	(1.11-1.54)
P-value <.001 .001 <.001 .001
Dyslipidemia
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 2.46	(2.04-2.96) 2.19	(1.81-2.66) 1.34	(1.02-1.76) 1.28	(0.97-1.69)
High	risk 2.48	(1.89-3.25) 2.02	(1.53-2.68) 2.23	(1.80-2.77) 1.91	(1.53-2.38)
Very	high	risk 3.58	(2.63-4.88) 2.84	(2.06-3.92) 2.66 (2.14 (3.30) 1.91	(1.50-2.43)
P-value <.001 <.001 <.001 <.001
MetS
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
(Continues)
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adults.25 We also found that adherence to western pattern was as-
sociated	with	higher	BMI.26,27
However,	there	are	several	conflicting	results	in	previous	inves-
tigations. Two prospective studies have shown that the association 
of	 BMI	 and	 coronary	 heart	 disease	 (CHD)	 is	 not	 different	 among	
males	 and	 females,	 though	 higher	 BMI	 significantly	 increased	 the	
risk	of	stroke	among	males.28,29	Also,	in	another	study	a	higher	BMI	
was found among CVD patients compared to healthy individuals.30 
According	to	the	EUROASPIRE	III	study,	obesity	is	a	more	common	




Several	 studies	 similar	 results	 have	 presented	 in	 CVD	 patients	 in	







males are the best anthropometric indicators of arterial stiffness as 
an	independent	cardiovascular	risk	factor.34
We have found that obesity categories could predict the pres-
ence	of	many	CVD	risk	factors	in	this	study.	We	demonstrated	that	
increased obesity categories were significantly correlated with the 






HDL	 and	 increased	 TC,	 TG,	 and	 LDL	 level	 (only	 in	 female)	 across	
obesity	categories.	In	a	recent	population-based	study,	these	signif-
icant	associations	were	not	 found	 for	 raised	TC,	TG	and	LDL,	and	
low	HDL.35	In	the	HERMES	study,	the	relationship	between	serum	
lipid profile and severity of obesity was investigated in obese pa-
tients.	The	results	 for	TG	and	HDL	were	significant.	However,	 the	
results	 for	TC	and	LDL	 showed	an	 insignificant	 relationship.36 We 
found that the obesity categories in men were associated with a 
significantly	higher	risk	of	 incidence	of	MetS	compared	with	these	
categories	 in	female	patients.	 In	contrast,	 in	a	study	conducted	by	
Yin	et	al	although	an	increase	in	risk	severity	of	obesity	categories	
was	associated	with	a	higher	risk	of	incidence	of	MetS,	the	odds	ratio	









Model 1 Model 2 Model 1 Model 2
Increased	risk 8.98	(6.94-11.61) 8	(6.15-10.40) 1.19	(0.94-1.50) 1.17	(0.93-1.48)
High	risk 21	(15.70-28.09) 17.42	(12.92-23.49) 3.20	(2.71-3.77) 2.99	(2.52-3.53)
Very	high	risk 33.51	(24.89-45.11) 26.95	(19.83-36.61) 5.04	(4.29-5.93) 4.42	(3.69-5.28)





TA B L E  4   (Continued)
 
Men Women
Model 1 Model 2 Model 1 Model 2
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.08	(0.66-1.74) 1.02	(0.62-1.67) 0.45	(0.15-1.34) 0.47	(0.16-1.39)
High	risk 1.87	(1.08-3.23) 1.65	(0.92-2.94) 1.12	(0.63-2) 1.07	(0.59-1.94)
Very	high	risk 1.65	(0.92-2.93) 1.44	(0.78-2.65) 1.91	(1.13-3.24) 1.91	(1.06-3.43)
P-value .090 .242 .016 .030
Note: Model	1,	unadjusted;	Model	2,	association	adjusted	for	age	category	(35-44,	45-54,	55-65),	
smoking	(ex-smoked	and	current	smoking)	and	physical	activity	level.	A	P-value	of	<	.05	was	
considered as statistically significant and the bold format.
TA B L E  5   Hazard ratio (HR) of 
cardiovascular disease events according to 
obesity categories








According	 to	 the	 results	 of	 the	 present	 study,	 obesity	 catego-
ries	 can	 strongly	predict	 the	presence	of	 several	CVD	 risk	 factors.	
Furthermore,	 our	 result	 suggested	 that	 increased	 obesity	 catego-
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